Samantha Lynn recalls
Samantha Lynn appears in 1 official U.S. recall notice indexed by RecallRadar, most recently on 2012-12-05.
Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.
Recall summary
| Recall notices | 1 |
|---|---|
| Published | 2012-12-05 |
| By agency | FDA Drug (1) |
| By classification | Class I (1) |
| By status | terminated (1) |
| Distribution named in notices | US |
Recalls
- Reumofan Plus Tablets, 30-count bottle per Box, (remaining label information in Spanish)
FDA Drug · Class I · 2012-12-05 · Samantha Lynn
Reason: Marketed without an approved NDA/ANDA: Samantha Lynn Inc. is recalling Reumofan Plus Tablets because it contains undeclared drug ingredients making it an unapproved drug.